Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating miricorilant in presumed nonalcoholic steatohepatitis has completed; the snippet does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Miricorilant (CORT118335)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Nonalcoholic Steatohepatitis (NASH) | Phase 1 | Status: COMPLETED